Go to content
UR Home

D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization

URN to cite this document:
Böttcher, Martin ; Renner, Kathrin ; Berger, Raffaela ; Mentz, Kristin ; Thomas, Simone ; Cardenas-Conejo, Zugey Elizabeth ; Dettmer, Katja ; Oefner, Peter J. ; Mackensen, Andreas ; Kreutz, Marina ; Mougiakakos, Dimitrios
Date of publication of this fulltext: 15 May 2018 08:35


D-2-hydroxyglutarate (D-2HG) is released by various types of malignant cells including acute myeloid leukemia (AML) blasts carrying isocitrate dehydrogenase (IDH) gain-of-function mutations. D-2HG acting as an oncometabolite promotes proliferation, anoikis, and differentiation block of hematopoietic cells in an autocrine fashion. However, prognostic impact of IDH mutations and high D-2HG levels ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons